Complication Rates for Percutaneous Coronary Intervention in South Australia Aashray Gupta1, Rosanna Tavella1,2, Margaret Arstall1,3, Matthew Worthley1,2,

Slides:



Advertisements
Similar presentations
STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.
Advertisements

CABG VS Multi Vessel PCI Hasanat Sharif MD FRCS Chief of Cardiorthoracic Surgery Aga Khan University Hospital.
K Fox, W Remme, C Daly, M Bertrand, R Ferrari, M Simoons On behalf of the EUROPA investigators. The diabetic sub study of.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.
5 Years Results of Off-Pump VS On-Pump CABG 5 Years Results of Off-Pump VS On-Pump CABG Prospective Non-randomized Comparative Study Piya Cherntanomwong*,
HEAPHY 1 & 2 CASE RACE 1 – DIAG Rowena OLIVER Sat 31 st Aug 2013 Session 3 / CR1-6 13:26 – 13:30 OTAGO / SOUTHLAND ABSTRACT A case of a 81 year old female.
Angiography Excessive Commercialisation Complications of Angiography 1.Death 2.Myocardial Infarction Factors predisposing Unstable angina Angina at rest.
National Report Card on Hospital care for heart disease in Indigenous Australia Traven Lea, National Manager, Aboriginal and Torres Strait Islander Program.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
WG Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,
Validation of Mayo Clinic Risk Adjustment Model for In-Hospital Mortality following Percutaneous Coronary Interventions using the National Cardiovascular.
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
Patterns of red blood cell transfusion use and outcomes in patients undergoing percutaneous coronary intervention in contemporary clinical practice: Insights.
Hamon M 1, Nienaber C 2, Galli S 3, Huber K 4, Gulba D 5, Hill J 6, Lafont A 7, Cequier A 8, Bernstein D 9, Deliargyris E 9 Institutions: 1. Centre Hospitalier.
ICE Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,
Revascularizaton of Ischemic DCM Percutaneous Revascularization and Hemodynamic Support Matthew R. Wolff, M.D. University of Wisconsin Disclosures: Cordis.
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
Bleeding in Patients Undergoing Percutaneous Coronary Interventions: A Risk Model From 302,152 Patients in the NCDR. Sameer K. Mehta MD, Andrew D. Frutkin.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Presenter Disclosure Information DISCLOSURE INFORMATION: The following relationships exist related to this presentation Stock options None; Consults for.
The Impact of For-Profit Hospital Status on the Care and Outcomes of Patients with NSTEMI: Results From CRUSADE Bimal R. Shah, MD, Seth W. Glickman, MD,
The Impact of For-Profit Hospital Status on the Care and Outcomes of Patients with NSTEMI: Results From CRUSADE Bimal R. Shah, MD, Seth W. Glickman, MD,
Bangalore S, et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13): ?
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Coronary Intervention Complications.
Insights from a Contemporary STEMI Prospective Registry
Consistency in diagnostic and treatment procedures Specifically angiography and angioplasty Dr Alison Round 14 October 2015.
Randomized vs. Observational Studies: Strengths and Weaknesses
A Clinical profile of patients enrolled in the Pakistan ACS registry
Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:
ASSOCIATION OF SOCIO-ECONOMIC POSITION WITH TECHNIQUE FAILURE AND MORTALITY IN AUSTRALIAN NON-INDIGENOUS PERITONEAL DIALYSIS PATIENTS Dr Samuel Chan Nephrology.
Costs of Periprocedural Complications in Patients Treated with Transcatheter Aortic Valve Replacement: Results from The PARTNER Trial Suzanne V. Arnold,
Thirty-day Readmissions Following CABG Surgery in New York JACC: Cardiovascular Interventions 2011;4(5): Hannan EL, Zhong Y, Lahey SJ, Culliford.
PCI related in-hospital mortality based on race and gender in the USA
Results of a kidney-protection strategy during open thoracoabdominal aortic surgery according to RIFLE criteria.
Women, Bleeding, and Coronary Intervention
Why Radial Access Should be the Default for Women undergoing PCI?
Successful CTO PCI Associated with Lower Mortality Risk
POISE-2 PeriOperative ISchemic Evaluation-2 Trial
Potentially avoidable issues in Surgical mortality: Findings of a national audit
Mortality Related to Periprocedural MI in CTO-PCI
FHA Collaborative on Reducing Readmissions in Florida
Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et.
Jeff Macemon Waikato Cardiothoracic Unit
The results of the SHARP trial
Dr. PJ Devereaux on behalf of POISE Investigators
VALUE Trial design: Hypertensive patients at high cardiovascular risk were randomized to valsartan (n = 7,649) vs. amlodipine (n = 7,596). Results (p =
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);
Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD, MPH, FACC,
Dr. PJ Devereaux on behalf of POISE Investigators
Global Registry of Acute Coronary Events: GRACE
Risk Stratification and Interventional Cardiology: Robert L
No Financial Disclosure or Conflict of Interest
Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p
pulmonary embolism protocol -- EMB review
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact  Jack V. Tu, MD, PhD, Anam M. Khan,
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
Characteristics of included studies
(A) Multivariable Cox regressions showing the association of higher CHA2DS2-Vasc scores (≥6) and (B) R2CHA2DS2-Vasc scores (≥7) with 1-year mortality (CABG,
Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.
The results of the SHARP trial
Glenn N. Levine et al. JACC 2011;58:e44-e122
Davide Capodanno et al. JCIN 2009;2:
Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.
Kaplan-Meier estimate of mortality in the two treatment strategies with significant difference between the two groups (log-rank test
Cardiovascular Epidemiology and Epidemiological Modelling
Figure 9.1.a Causes of death in ESRD patients,
Presentation transcript:

Complication Rates for Percutaneous Coronary Intervention in South Australia Aashray Gupta1, Rosanna Tavella1,2, Margaret Arstall1,3, Matthew Worthley1,2, Derek Chew4,5, Christopher Zeitz1,2, John Beltrame1,2 1 Discipline of Medicine, The University of Adelaide 2 Central Adelaide Local Health Network, SA Health 3 Northern Adelaide Local Health Network, SA Health 4 School of Medicine, Flinders University 5 Southern Adelaide Local Health Network, SA Health

BACKGROUND Coronary Artery Disease (CAD) causes death and disability Often treated with Percutaneous Coronary Intervention (PCI) Contemporary complication rates of PCI are uncertain Currently based on historic data Important for advising patients of risk and benefits of procedure

PERCUTANEOUS CORONARY INTERVENTION (PCI)

PCI – BALANCING RISKS AND BENEFITS Potential Benefits Relieves chest pain Improves survival  MI  Re-hospitalisation Potential Risks Death Cardiac Complications Stroke Bleeding Kidney injury

PCI – CURRENT SA HEALTH CONSENT FORM Complications Rate (per 1000 procedures) Death 4 Heart Attack Stroke 1 Emergency Bypass Surgery 3 Kidney Damage 5

AIM To document contemporary complication rates of PCI using a statewide data-set Peripheral and Cardiac events

METHODOLOGY Coronary Angiogram Database Of South Australia (CADOSA) Registers all PCI Procedures in SA Public Hospitals Data collected by trained abstractor Standardised definitions Consistent with international studies

RESULTS – PATIENT CHARACTERISTICS All Procedures in 2013 (n = 1517) 74% of patients were male Average age: 63 ±12 years Acuity – 76% Acute, 24% Elective Access – 59% Radial, 41% Femoral PCI complication rate – 5.3%, Success Rate = 94.7% In-hospital Mortality Rate – 1.7%

COMPLICATIONS BY PROCEDURE ACUITY

COMPLICATIONS BY ACCESS SITE

RESULTS – PERIPHERAL COMPLICATIONS Rate (%) Acute Kidney Injury Minor Injury (Cr  30 µmol/L) 5.1 Major Injury (new dialysis) 0.3 Major Bleeding Hb  30 g/L 1.7 Blood Transfusion 0.9 Stroke Embolic Stroke Haemorrhagic Stroke

RESULTS – CARDIAC COMPLICATIONS Rate (%) New Cardiogenic Shock (BP < 90 mmHg) 2.4 New Congestive Heart Failure (CHF) 1.3 Periprocedural MI Emergency CABG 0.2

RESULTS – CARDIAC COMPLICATIONS Our Study Stathopoulos et al (2009) (N= 23,399) ACC PCI Guidelines** Mortality 1.7% 0.6% 1.3% Stroke 0.3% 0.2% Bleeding 2-6% Emergency CABG 0.4% Periprocedural MI 0.7% Major Kidney Injury Overall Rate 5.3% 3.4% *Stathopoulos et al, 2009, ** ACC/AHA PCI Guidelines 2011

RESULTS IN CONTEXT In-hospital Events SA Consent Form CADOSA (cases/1,000 procedures) Mortality 4 17 Stroke 1 3 Emergency CABG Periprocedural MI 13 Major Kidney Injury 5 Major Bleeding - New Cardiogenic Shock 24 New Heart Failure

CONCLUSIONS Actual complications differ from current consent form Rates of Mortality, Stroke, Periprocedural MI higher Rate of Major Kidney Injury lower Complication rates not previously reported: Bleeding New Cardiogenic Shock New Congestive Heart Failure

Need for ongoing surveillance of complications IMPLICATIONS Need for ongoing surveillance of complications Important to guide quality improvement efforts Essential for informed consent Need to update PCI consent form

ACKNOWLEDGEMENTS Supervisors Dr Rosanna Tavella Prof John Beltrame Collaborators from the CADOSA Registry